Luis V. García

发表

Preliminary Assessment of the Safety and Immunogenicity of a New CTXΦ-Negative, Hemagglutinin/Protease-Defective El Tor Strain as a Cholera Vaccine Candidate

Anisia J. Silva, J. Benitez, T. Valmaseda, 1999, Infection and Immunity.

Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi

O. Pérez, Luis V. García, J. Pérez, 2013, BMC Immunology.

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A

O. Pérez, Luis V. García, B. Cedré, 2014, Immunologic research.

Cochleates Derived from Vibrio cholerae O1 Proteoliposomes: The Impact of Structure Transformation on Mucosal Immunisation

O. Pérez, Luis V. García, B. Cedré, 2012, PloS one.

Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats.

A. Talavera, Luis V. García, B. Cedré, 2011, Vaccine.

A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice.

A. Talavera, O. Pérez, Luis V. García, 2009, Vaccine.

A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae.

A. Talavera, Luis V. García, B. Cedré, 2011, Vaccine.

The Vaccine Candidate Vibrio cholerae 638 Is Protective against Cholera in Healthy Volunteers

A. Talavera, T. Valmaseda, O. Pérez, 2005, Infection and Immunity.

Construction and Characterization of a Nonproliferative El Tor Cholera Vaccine Candidate Derived from Strain 638

T. Valmaseda, Luis V. García, R. Fando, 2000, Infection and Immunity.

Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults.

G. Kourí, G. Sierra, Luis V. García, 2009, Vaccine.

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice.

O. Pérez, Luis V. García, B. Cedré, 2009, Methods.

Construction and characterisation of O139 cholera vaccine candidates.

T. Valmaseda, Luis V. García, H. García, 2003, Vaccine.

Strain as a Cholera Vaccine Candidate Hemagglutinin / Protease-Defective El Tor-Negative , Φ Immunogenicity of a New CTX Preliminary Assessment of the Safety and

Anisia J. Silva, J. Benitez, T. Valmaseda, 1999 .

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A

O. Pérez, Luis V. García, B. Cedré, 2013, Immunologic Research.

[Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].

A. Talavera, T. Valmaseda, Luis V. García, 2005, Revista cubana de medicina tropical.

A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae.

A. Talavera, Luis V. García, B. Cedré, 2011, Vaccine.